A Study to Evaluate Safety and Efficacy of KM-819 in Healthy Adults and Participants with Parkinson's Disease
- First Posted Date
- 2023-01-04
- Last Posted Date
- 2025-03-05
- Lead Sponsor
- FAScinate Therapeutics Inc.
- Target Recruit Count
- 314
- Registration Number
- NCT05670782
- Locations
- 🇺🇸
University California San Diego Medical Center, San Diego, California, United States
🇺🇸Quest Research Institute, Rose Cancer Center, Royal Oak, Michigan, United States
🇺🇸Parexel Early Phase Clinical Unit, Glendale, California, United States
© Copyright 2025. All Rights Reserved by MedPath